• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH CREATININE_2 (CREA_2); CREATININE_2 ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH CREATININE_2 (CREA_2); CREATININE_2 ASSAY Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/15/2023
Event Type  malfunction  
Manufacturer Narrative
An outside the united states customer observed falsely depressed creatinine_2 (crea_2) results on six patient samples on an atellica ch analyser, lot 221736.The erroneous results were reported to the physician(s).The results were not questioned by the physician(s).The samples were reprocessed on an original instrument.The repeat results were higher than the initial results.The repeat results were considered as correct results by the physician(s).Quality controls (qc) were in range at the time of the event.The interpretation of results section of the atellica ch crea_2 instructions for use (ifu) states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings.".Siemens healthcare diagnostics is investigating.
 
Event Description
The customer observed falsely depressed creatinine_2 (crea_2) results on six patient samples on an atellica ch analyser, lot 221736.The erroneous results were reported to the physician(s).The results were not questioned by the physician(s).The samples were reprocessed on an original instrument.The repeat results were higher than the initial results.The repeat results were considered as correct results by the physician(s).There are no known reports of patient intervention or adverse health consequences due to the falsely depressed crea_2 results.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2023-00086 on apr 13, 2023.Additional information: apr 21, 2023 and may 04, 2023: the customer observed falsely depressed creatinine_2 (crea_2) results on six patient samples on an atellica ch analyser, lot 221736.The erroneous results were reported to the physician(s).The results were not questioned by the physician(s).The samples were reprocessed on the original instrument.The repeat results were higher than the initial results.The repeat results were considered as correct results by the physician(s).The customer provided the gender of all patient samples.Sample ids gender (b)(6) male (b)(6) male (b)(6) female (b)(6) female (b)(6) male (b)(6) female siemens was unable to obtain information to determine if there is an indication of reagent delivery, or if there is evidence that a foaming issue occurred without photometer or result monitor data.No maintenance information was available for atellica cm01751.Siemens was unable to query atellica cm01751 for process errors posted on (b)(6) 2023.The initial issue was reported as discordant (low) atellica creatinine_2 (crea_2) results.Siemens cannot definitively determine the cause of this discrepant result.Contributing factors such as sample integrity, preanalytical variables cannot be ruled out.Quality control was in range and no issues were noted with other patient samples indicating that the instrument and reagents were performing acceptably.Repeat of the same sample yielded expected results.Based on the results of the investigation, return of the patient sample is not warranted.A potential product issue has not been identified.Customer instrument is fully functional.In section h6, the investigation finding, and investigation conclusion codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA CH CREATININE_2 (CREA_2)
Type of Device
CREATININE_2 ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
RANDOX LABORATORIES LTD.
registration # 8020890
55 diamond road
crumlin co. antrim, BT29 4QY
UK   BT29 4QY
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
7818564812
MDR Report Key16732806
MDR Text Key313221562
Report Number1219913-2023-00086
Device Sequence Number1
Product Code CGX
UDI-Device Identifier00630414596457
UDI-Public00630414596457
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K161494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/01/2023
Device Model NumberN/A
Device Catalogue Number11097596
Device Lot Number221736
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/20/2023
Initial Date FDA Received04/13/2023
Supplement Dates Manufacturer Received04/21/2023
Supplement Dates FDA Received05/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/01/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-